Inventurus Knowledge Solutions Limited · NSE:IKS

Inventurus Knowledge Solutions — Q3 FY2026 Earnings Presentation

16 slides from Inventurus Knowledge Solutions's earnings presentation, Feb 4, 2026

  1. Slide 1: Exchange filing cover letter: Investor Presentation

    February 4, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maha

  2. Slide 2: IKS Health Q3 FY26 Investor Presentation

    IKS Health Q3 FY 26 Investor Presentation 1

  3. Slide 3: Disclaimer

    Disclaimer This presentation may include opinions and assumptions about future performance which could be considered as forward-looking statements. Forward-looking statements intrinsically cover several risks and uncertainties, which may lead to a material difference between actual results and the s

  4. Slide 4: IKS Health - a comprehensive healthcare enablement platform empowering provider organizations

    IKS Health - a comprehensive healthcare enablement platform empowering provider organizations US$260bn / US$34bn US$5tn 8% / 12% Total TAM / Outsourced Market TAM / Outsourced Market US Healthcare Addressable Expenditure (CY2024) (CY2023) CAGR (2023-2028E) Market1,2 The only Comprehensive platform t

  5. Slide 5: IKS Health: Strategic Pillars of execution

    IKS Health: 5 Strategic Pillars of execution Establishing AQuity Acquisition Leadership across Differentiated Evolution Towards an AI-native. Agentic Integration & features; while Growth Market Outcome-Oriented Platform Manifest Optimization driving platform Strategy Company uniqueness - Launched int

  6. Slide 6: Awards and Recognition

    Awards and Recognition 2026 Best in KLAS Award for Virtual Scribing Services ● IKS has been recognized for the second time by KLAS Research as Best in KLAS provider for Virtual Scribe Services, receiving a 91.9 score out of 100 and earning As in four of the five customer experience areas ● KLAS ranki

  7. Slide 7: IKS Health enables care transformation across the patient journey

    IKS Health enables care transformation across the patient journey Automation Level Automation Level Automation Level Automation Level Optimized Patient Patient Prospective Pre-Visit Scheduling Financial Engagement Clinical Chart Clearance Hub Reviews Automation Level Automation Level Automation Leve

  8. Slide 8: Q3 - Strong growth while delivering continuous margin expansion

    Q3 - Strong growth while delivering continuous margin expansion Deep Client Globally Diversified Growth At Scale Strong Margin Profile Relationships Workforce INR 8,150 mn 450+ 35% 13,350 Revenue from Enterprise level EBITDA Total Employees Operations customers 24% INR mn 3,943/48% 22% 2,072 / 542 YoY

  9. Slide 9: Key Deal Wins

    Key Deal Wins VitalMD Group Holding, a Florida-based physician owned and led medical practices of over 800 providers providing multispecialty services, and Femwell Group Health, its Florida-based MSO, have expanded their long-standing partnership with IKS Health to include the ambient solutions that

  10. Slide 10: Q3 FY26: Growing faster than market with improving margins

    Q3 FY 26: Growing faster than market with improving margins Revenue EBITDA INR Mn INR Mn 2,816 2,718 24.0% YoY 40.4% YoY 7,811 8,150 2,006 6,572 34.6% 4.3% QoQ 34.8% 3.6% QoQ 30.5% Q3 FY25 Q2 FY26 Q3 FY26 Q3 FY25 Q2 FY26 Q3 FY26 PAT* Adjusted PAT** INR Mn INR Mn 2,154 1,807 1,833 1,981 41.4% YoY 48.

  11. Slide 11: Q3 FY26 - Improving EPS and maintaining high ROE

    Q3 FY 26 - Improving EPS and maintaining high ROE EPS ₹* ROE* % 40.5% YoY 1.4% QoQ EPS is calculated as profit for the period divided by weighted average Return on Equity is calculated as profit for the period divided by total number of equity shares as defined in IND AS 33. equity at the end of the pe

  12. Slide 12: Q3 FY26 - Continued strong cash generation supporting growth aspirations

    Q3 FY 26 - Continued strong cash generation supporting growth aspirations OCF & FCF Net Debt INR Mn INR Mn 84.8% OCF YoY 79.9% FCF YoY OCF and FCF are adjusted for upfront guarantee payment of economic value add made to a customer, for Rs 899 mn in Q3 FY 26. 11

  13. Slide 13: 9M FY26 - Strong Cash Generation and EPS Growth

    9M FY 26 - Strong Cash Generation and EPS Growth OCF & FCF INR Mn EPS ₹* 31 49.8% OCF YoY 49.8% FCF YoY 20 51.5% YoY 9M FY 25 9M FY 26 EPS is calculated as profit for the period divided by weighted average number of equity shares as defined in IND AS 33. EPS includes a ₹127 million non-recurring, non-

  14. Slide 14: A Decade of Consistent Profitable Growth

    A Decade of Consistent Profitable Growth 27.9% 32.3% Revenue CAGR PAT CAGR 13

  15. Slide 15: Financials - Summary INR millions

    Financials - Summary INR millions INR Mn Particulars Q3 FY 26 Q2 FY 26 QoQ% Q3 FY 25 YoY% 9m FY 26 9m FY 25 YoY% Revenue USD mn 93 90 2.5% 78 18.7% 269 231 16.5% Revenue 8,150 7,811 4.3% 6,572 24.0% 23,361 19,400 20.4% Other Income - Operating - - 0.0% 134 -100.0% 176 -100.0% Forex Gain/ (Loss) 87 1

  16. Slide 16: Other KPI Metrics

    Other KPI Metrics Particulars Q3 FY 26 Q2 FY 26 Q3 FY 25 Annualised EBITDA per employee in INR mn 0.91 0.91 0.64 Revenue from Top 10 customers INR mn 3,943 3,548 2,724 Contribution from Top 10 customers 48.4% 45.4% 41.4% Revenue from Top 5 customers INR mn 2,768 2,628 1,806 Contribution from Top 5 c

Inventurus Knowledge Solutions — Q3 FY2026 Earnings Presentation on 6ix